secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001493152-25-006052
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus enters $20M standby equity line with Yorkville; issues 305,960 commitment shares
--------------------------------------------------------------------------------

- Up to $20M equity purchase agreement with YA II PN (Yorkville) over 36 months.
- Shares sold at 97% of lowest 3-day VWAP; 305,960 commitment shares and $25k fee issued.
- Exchange cap 2,823,244 shares (19.99% of outstanding) unless price ≥$0.81722 or shareholder approval.
- Terminates prior Lincoln Park Capital purchase agreement from December 2022.
- Registration statement required before any advances can be drawn.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000149315225006052/0001493152-25-006052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000149315225006052/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer